Introduction
Obynac SP Tablet by Astemax Biotech combines aceclofenac 100 mg, paracetamol 325 mg, and serratiopeptidase 15 mg in a powerful triple-action formula for comprehensive pain relief and inflammation control. This high-quality gastro-friendly tablet reduces swelling, breaks down inflammatory debris, and manages fever effectively, produced in WHO-GMP certified facilities.
Tablet Composition
Obynac SP features aceclofenac for potent NSAID analgesia, paracetamol for fever reduction and pain modulation, and serratiopeptidase as a proteolytic enzyme that degrades dead tissue and fibrin. The balanced synergy targets musculoskeletal pain without excessive gastric irritation. Packaged in 10×10 alu-alu strips for convenience.
Primary Benefits
-
Provides rapid relief from arthritis pain, post-surgical inflammation, sprains, and dental pain.
-
Serratiopeptidase accelerates edema reduction and speeds tissue repair by 30-40%.
-
Enhanced pain control with minimal GI side effects compared to aceclofenac alone.
Quality Manufacturing
Astemax Biotech crafts Obynac SP in advanced WHO-GMP certified plants, ensuring purity, uniform dissolution, and stability. Ethical marketing emphasizes evidence-based musculoskeletal therapy for clinical reliability.
Action Mechanism
Aceclofenac inhibits COX-2 enzymes to cut prostaglandin synthesis, paracetamol elevates pain thresholds centrally, and serratiopeptidase hydrolyzes inflammatory proteins for faster debridement. This multi-pathway approach delivers superior efficacy in acute and chronic pain.
